Author

Fengqiang Cui

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

LMAN2 promotes breast cancer progression and deduces cell sensitivity to doxorubicin through stearoyl-CoA desaturase

LMAN2 is a robust prognostic biomarker that promotes breast tumor growth and anthracycline resistance by enabling SCD-dependent lipid desaturation and Therapeutic targeting of the LMAN2/SCD axis represents a promising strategy to overcome chemoresistance in breast cancer.

Chang-Jiao Yan, Feng-Qiang Cui, Chu-Tuo Liu et al. · Breast Cancer Research · 0 citations

Open access Jul 2026

NSUN2 regulates PARP9 progression through m5C modification to mediate breast cancer progression.

BACKGROUND m5C modification plays a vital role in the progression of human cancers, including breast cancer (BC), but the function of NOP2/Sun RNA methyltransferase 2 (NSUN2), an RNA m5C modification enzyme, remains largely unclear. METHODS qRT-PCR, western blot and IHC assays were carried out to determine the expres...

Xin Li, Changjiao Yan, Jun Yi et al. · Cell Division · 0 citations